- Tytuł:
- Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial
- Autorzy:
- Źródło:
- In European Journal of Cancer September 2021 154:296-306
Czasopismo naukowe